Pharma and Biotech
Competitors: | Hemogenyx Pharmaceuticals |
Executive Director: | Daniel Gooding |
Independent Non-Executive Director: | Madeleine Kennedy |
Non-Executive Chairman: | Julian Gilbert |
Non-Executive Dir: |
Address: | C/O Arch Law Limited, Huckletree Bishopsgate, 8 Bishopsgate, London, United Kingdom, EC2N 4BQ |
Phone: | +44 (0)1223 627222 |
Website: | https://nuformix.com/ |
Sector: | Pharma and Biotech(LSE) |
ISIN: | GB00BYW79Y38 |
Currency | UK Pounds |
Share Price | 0.11p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 0.16 |
52 Week Low | 0.048 |
Volume | 17,125,480 |
Shares Issued | 1,995.71m |
Market Cap | £2.10m |
RiskGrade | 322 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
10:24 | 103,008 @ 0.11p |
10:20 | 200,000 @ 0.095p |
09:35 | 217,000 @ 0.095p |
09:19 | 4,019,169 @ 0.096p |
09:03 | 364,044 @ 0.097p |
You are here: research